Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

NYSE:EXK - New York Stock Exchange, Inc. - CA29258Y1034 - Common Stock - Currency: USD

5.57  -0.05 (-0.89%)

Premarket: 5.62 +0.05 (+0.9%)

Fundamental Rating

3

Taking everything into account, EXK scores 3 out of 10 in our fundamental rating. EXK was compared to 154 industry peers in the Metals & Mining industry. EXK has a bad profitability rating. Also its financial health evaluation is rather negative. EXK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
EXK had positive earnings in 4 of the past 5 years.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK's Return On Assets of -8.68% is on the low side compared to the rest of the industry. EXK is outperformed by 69.48% of its industry peers.
EXK's Return On Equity of -13.98% is on the low side compared to the rest of the industry. EXK is outperformed by 65.58% of its industry peers.
EXK's Return On Invested Capital of 1.17% is in line compared to the rest of the industry. EXK outperforms 48.70% of its industry peers.
EXK had an Average Return On Invested Capital over the past 3 years of 2.76%. This is significantly below the industry average of 11.67%.
Industry RankSector Rank
ROA -8.68%
ROE -13.98%
ROIC 1.17%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK has a Operating Margin (4.23%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EXK has declined.
EXK's Gross Margin of 19.90% is in line compared to the rest of the industry. EXK outperforms 57.79% of its industry peers.
EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.23%
PM (TTM) N/A
GM 19.9%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

EXK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
Compared to 5 years ago, EXK has more shares outstanding
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXK has an Altman-Z score of 3.09. This indicates that EXK is financially healthy and has little risk of bankruptcy at the moment.
EXK has a Altman-Z score of 3.09. This is comparable to the rest of the industry: EXK outperforms 57.14% of its industry peers.
EXK has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
EXK has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 3.09
ROIC/WACC0.13
WACC8.73%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 1.14. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EXK (1.14) is worse than 81.17% of its industry peers.
A Quick Ratio of 0.77 indicates that EXK may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, EXK is not doing good in the industry: 79.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.77
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The earnings per share for EXK have decreased strongly by -900.00% in the last year.
Looking at the last year, EXK shows a small growth in Revenue. The Revenue has grown by 1.72% in the last year.
EXK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.33% yearly.
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.36%

3.2 Future

EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.85% yearly.
The Revenue is expected to grow by 29.85% on average over the next years. This is a very strong growth
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y55.85%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y29.85%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 11.99, the valuation of EXK can be described as reasonable.
72.08% of the companies in the same industry are more expensive than EXK, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, EXK is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 11.99
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.93
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

EXK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXK's earnings are expected to grow with 74.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y179.42%
EPS Next 3Y74.85%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (7/17/2025, 8:20:35 PM)

Premarket: 5.62 +0.05 (+0.9%)

5.57

-0.05 (-0.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners42.36%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap1.61B
Analysts78.33
Price Target6.1 (9.52%)
Short Float %10.94%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2514.86%
Min EPS beat(2)-5248.51%
Max EPS beat(2)218.79%
EPS beat(4)1
Avg EPS beat(4)-1807.45%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-976.72%
EPS beat(12)2
Avg EPS beat(12)-706.48%
EPS beat(16)3
Avg EPS beat(16)-553.55%
Revenue beat(2)1
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-16.69%
Max Revenue beat(2)0.11%
Revenue beat(4)3
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)6.54%
Revenue beat(8)5
Avg Revenue beat(8)-2.1%
Revenue beat(12)7
Avg Revenue beat(12)-1.99%
Revenue beat(16)8
Avg Revenue beat(16)-2.69%
PT rev (1m)-0.27%
PT rev (3m)4.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)24.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.99
P/S 7.42
P/FCF N/A
P/OCF 90.13
P/B 3.57
P/tB 3.57
EV/EBITDA 40.93
EPS(TTM)-0.2
EYN/A
EPS(NY)0.46
Fwd EY8.34%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)0.06
OCFY1.11%
SpS0.75
BVpS1.56
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.68%
ROE -13.98%
ROCE 1.48%
ROIC 1.17%
ROICexc 1.31%
ROICexgc 1.31%
OM 4.23%
PM (TTM) N/A
GM 19.9%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexcg growth 3Y-31.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 2.76
Cap/Depr 608.79%
Cap/Sales 88.35%
Interest Coverage 1.28
Cash Conversion 43.91%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.77
Altman-Z 3.09
F-Score3
WACC8.73%
ROIC/WACC0.13
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y342.4%
EPS Next 2Y179.42%
EPS Next 3Y74.85%
EPS Next 5Y55.85%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%-0.36%
Revenue Next Year94.75%
Revenue Next 2Y70.46%
Revenue Next 3Y33.75%
Revenue Next 5Y29.85%
EBIT growth 1Y80.46%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year214.33%
EBIT Next 3Y84.98%
EBIT Next 5Y53.06%
FCF growth 1Y-105.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.55%
OCF growth 3Y-6.61%
OCF growth 5YN/A